Add thelocalreport.in As A Trusted Source
Amazon Now available in pharmacies wiggsIt is the first oral GLP-1 weight loss drug approved by the FDA, providing patients with a convenient new management option. obesity.
Made by Novo Nordisk, drug Amazon announced Friday that it will be available for both insured and self-pay patients through the retailer’s online pharmacy.
Eligible insured customers can pay just $25 for a month’s supply, while uninsured customers can spend about $149 per month. Amazon Pharmacy allows customers to compare insurance and cash prices side-by-side online, with applicable coupons automatically applied at checkout and delivery prescription Nationwide, including same-day service in many U.S. markets.
Wegovy pills will also be available at prescription kiosks at select One Medical clinics in the coming weeks, Amazon said. Although the drug is becoming more readily available, GLP-1 drugs generally require a physician’s evaluation and prescription.
The oral formulation launched this week contains semaglutide, the same active ingredient found in the widely used injectable Wegovy, ozonefor patients who prefer medications over injection A new treatment option.
The U.S. Food and Drug Administration (FDA) approved the drug in December, with clinical data showing significant weight loss when combined with diet and exercise.
Wegovy pills are also sold in more than 70,000 retail pharmacies, including major chains such as CVS and Costco. Additionally, medications are available through select telemedicine providers such as Ro, LifeMD, Weight Watchers, GoodRx and Novo Nordisk’s own NovoCare Pharmacy.
Patients who pay cash will soon be able to get a starting dose of the Wegovy pill for $149 a month. President Donald Trump’s direct-to-consumer websites, Trump Prescription.
In November, the Trump administration Make a deal Partnering with Eli Lilly and Novo Nordisk to lower GLP-1 drug costs. With TrumpRx and expanded Medicare/Medicaid coverage, price plans for the oral version drop to around $350 per month, or less, with Medicare copays of about $50, down from a sticker price of more than $1,000. TrumpRxis is set to launch later this month, but a specific date has not yet been announced.
trump told new york times In a wide-ranging conversation Wednesday, he never took GLP-1 diet pills like Wegovy or Zepbound, but admitted, “I probably should.”
amazon pharmacy, Launching in 2020It stems from Amazon’s acquisition of PillPack in 2018 and One Medical in 2022 as part of its entry into the U.S. healthcare market. The company works with long-term weight loss programs Weight Watchers It has partnered with pharmaceutical company Eli Lilly to offer weight-loss drugs, including Eli Lilly’s obesity drug Zepbound.
Eli Lilly also has a competing weight loss drug, Orforglipron, which is expected to receive FDA approval later this year.